US Dialysis Market Analysis Report [2022-30] I Insights10

US Dialysis Market Analysis

$ 3999

The US Dialysis Market is projected to grow from $48.808 Bn in 2022 to $69.410 Bn by 2030, registering a CAGR of 4.5% during the forecast period of 2022 - 2030. The market for dialysis services in the US is anticipated to be driven by rising rates of high blood pressure and diabetes. Fresenius Medical Care company is the largest provider of dialysis services and products in the world and is the leader in the US market, with a significant market share.

ID: IN10USPH010 CATEGORY: Pharmaceuticals GEOGRAPHY: US AUTHOR: Shivam Zalke

Buy Now

US Dialysis Market Executive Summary

The US Dialysis Market is projected to grow from $48.808 Bn in 2022 to $69.410 Bn by 2030, registering a CAGR of 4.5% during the forecast period of 2022 - 2030.

In 2020, US national health expenditure was seen to rise high up to 19.7% of its Gross Domestic Product (GDP) from 17.6% in 2019. According to World Health Organization (WHO) Global Health Expenditure database, US healthcare expenditure per capita raised to $10,921.01 as compared to $ 10,515.32 in 2018. Healthcare spending in the US has been growing at a faster rate than the overall economy for many years.

The U.S. dialysis market is a large and growing industry, driven by an aging population and an increasing incidence of chronic kidney disease. The market is dominated by a few large players, including Fresenius Medical Care, DaVita, and American Renal Associates. The market is segmented into in-center dialysis and home dialysis, with in-center dialysis being the most widely used. The market is also segmented by end-users, including hospitals, dialysis centers, and home care settings. The market is expected to continue to grow in the coming years, driven by factors such as an aging population, an increasing incidence of chronic kidney disease, and advances in technology.

us dialysis market analysis

Market Dynamics

Market Drivers

Dialysis, which comes in two varieties—hemodialysis and peritoneal—performs normal kidney functions by removing extra fluid and waste from the blood. Dialysis is a treatment for people whose kidneys are failing. End-stage renal disease (ESRD), also known as stage 5 CKD or kidney failure, is the stage at which chronic kidney disease (CKD) has progressed to the point that it no longer has the ability to clean and filter blood as well as healthy kidneys do. In the absence of treatment, the body builds up harmful poisons and waste. At this stage, receiving dialysis therapy is necessary to extend life until a kidney transplant is carried out. Diabetes and high blood pressure increase the risk of renal failure, which eventually necessitates dialysis or a kidney transplant. The market for dialysis services in the US is anticipated to be driven by rising rates of high blood pressure and diabetes.

Competitive Landscape

Key Players

The key players in the US Dialysis Market include:

Fresenius Medical Care: This company is the largest provider of dialysis services and products in the world and is the leader in the US market, with a significant market share
DaVita: This company is the second-largest dialysis provider in the US and offers a wide range of services, including in-center and home dialysis
American Renal Associates: This company is one of the largest independent dialysis providers in the US, with a strong presence in the in-center dialysis market
Nephron Pharmaceuticals: A company that specializes in the manufacturing and distribution of dialysis products and services
NxStage Medical: This company specializes in home and acute dialysis products and services
Dialysis Clinic Inc (DCI): This company is one of the largest non-profit dialysis providers in the US
Satellite Healthcare: This company is one of the largest non-profit dialysis providers in the US

These companies have a strong presence in the market and have been expanding their operations through acquisitions and partnerships with other providers.

Healthcare Policies and Regulatory Landscape

The US dialysis market is heavily regulated by the government, primarily through the Centers for Medicare and Medicaid Services (CMS) and the Food and Drug Administration (FDA). Some of the key healthcare policies and regulations that impact the dialysis market include:

ESRD prospective payment system: This system is used by CMS to pay for dialysis services provided to Medicare beneficiaries, and it sets reimbursement rates for these services based on a complex formula that takes into account various factors such as the type of treatment and the location of the facility
Quality Incentive Program (QIP): This program is used by CMS to incentivize dialysis providers to improve the quality of care for their patients by linking reimbursement rates to performance on a set of quality measures
Dialysis Facility Compare: This website maintained by CMS provides information to patients and caregivers about the quality of care provided by dialysis facilities
FDA oversight: The FDA regulates the safety and efficacy of dialysis products and equipment, such as dialysis machines, filters, and solutions
Affordable Care Act: The Affordable Care Act (ACA) expanded access to healthcare coverage for many Americans, which has increased the number of people with kidney disease who have insurance coverage for dialysis treatments
The Centers for Disease Control and Prevention (CDC) and the National Kidney Foundation (NKF) have also issued guidelines and standards of care for dialysis providers to adhere to

These policies and regulations help to ensure that dialysis services are provided in a safe and effective manner and that patients have access to the care they need.

1. Executive Summary
1.1 Disease Overview
1.2 Global Scenario
1.3 Country Overview
1.4 Healthcare Scenario in Country
1.5 Patient Journey
1.6 Health Insurance Coverage in Country
1.7 Active Pharmaceutical Ingredient (API)
1.8 Recent Developments in the Country

2. Market Size and Forecasting
2.1 Epidemiology of Disease
2.2 Market Size (With Excel & Methodology)
2.3 Market Segmentation (Check all Segments in Segmentation Section)

3. Market Dynamics
3.1 Market Drivers
3.2 Market Restraints

4. Competitive Landscape
4.1 Major Market Share

4.2 Key Company Profile (Check all Companies in the Summary Section)

4.2.1 Company
4.2.1.1 Overview
4.2.1.2 Product Applications and Services
4.2.1.3 Recent Developments
4.2.1.4 Partnerships Ecosystem
4.2.1.5 Financials (Based on Availability)

5. Reimbursement Scenario
5.1 Reimbursement Regulation
5.2 Reimbursement Process for Diagnosis
5.3 Reimbursement Process for Treatment

6. Methodology and Scope

Dialysis Market Segmentation

The Dialysis Market is segmented as mentioned below:

By Type (Revenue, USD Billion):

Hemodialysis (HD)
- Conventional Hemodialysis
- Short daily hemodialysis
- Nocturnal hemodialysis
Peritoneal dialysis (PD)
- Continuous Ambulatory Peritoneal Dialysis (CAPD)
- Automated Peritoneal Dialysis (APD)

By Product & Services (Revenue, USD Billion):

Equipment
- Dialysis Machines
- Water Treatment Systems
- Others Dialysis Equipment
Consumables
- Dialyzers
- Catheters
- Other Dialysis Consumables
Dialysis Drugs
Services

By End User (Revenue, USD Billion):

In-center dialysis
Home dialysis

Methodology for Database Creation

Our database offers a comprehensive list of healthcare centers, meticulously curated to provide detailed information on a wide range of specialties and services. It includes top-tier hospitals, clinics, and diagnostic facilities across 30 countries and 24 specialties, ensuring users can find the healthcare services they need.

Additionally, we provide a comprehensive list of Key Opinion Leaders (KOLs) based on your requirements. Our curated list captures various crucial aspects of the KOLs, offering more than just general information. Whether you're looking to boost brand awareness, drive engagement, or launch a new product, our extensive list of KOLs ensures you have the right experts by your side. Covering 30 countries and 36 specialties, our database guarantees access to the best KOLs in the healthcare industry, supporting strategic decisions and enhancing your initiatives.

How Do We Get It?

Our database is created and maintained through a combination of secondary and primary research methodologies.

1. Secondary Research

With many years of experience in the healthcare field, we have our own rich proprietary data from various past projects. This historical data serves as the foundation for our database. Our continuous process of gathering data involves:

Analyzing historical proprietary data collected from multiple projects.
Regularly updating our existing data sets with new findings and trends.
Ensuring data consistency and accuracy through rigorous validation processes.

With extensive experience in the field, we have developed a proprietary GenAI-based technology that is uniquely tailored to our organization. This advanced technology enables us to scan a wide array of relevant information sources across the internet. Our data-gathering process includes:

Searching through academic conferences, published research, citations, and social media platforms
Collecting and compiling diverse data to build a comprehensive and detailed database
Continuously updating our database with new information to ensure its relevance and accuracy

2. Primary Research

To complement and validate our secondary data, we engage in primary research through local tie-ups and partnerships. This process involves:

Collaborating with local healthcare providers, hospitals, and clinics to gather real-time data.
Conducting surveys, interviews, and field studies to collect fresh data directly from the source.
Continuously refreshing our database to ensure that the information remains current and reliable.
Validating secondary data through cross-referencing with primary data to ensure accuracy and relevance.

Combining Secondary and Primary Research

By integrating both secondary and primary research methodologies, we ensure that our database is comprehensive, accurate, and up-to-date. The combined process involves:

Merging historical data from secondary research with real-time data from primary research.
Conducting thorough data validation and cleansing to remove inconsistencies and errors.
Organizing data into a structured format that is easily accessible and usable for various applications.
Continuously monitoring and updating the database to reflect the latest developments and trends in the healthcare field.

Through this meticulous process, we create a final database tailored to each region and domain within the healthcare industry. This approach ensures that our clients receive reliable and relevant data, empowering them to make informed decisions and drive innovation in their respective fields.